Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene

FEBS Letters

Volumn 392, Issue 1, 1996, Pages 30-34

  Løvlie, Roger ^a   Daly, Ann K ^b   Molven, Anders ^a   Idle, Jeffrey R ^b,c   Steen, Vidar M ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

CYP2D6 genotyping; Debrisoquine 4 hydroxylase; Gene duplication; Long PCR; Ultrarapid metabolizer

Indexed keywords

CYTOCHROME P450; DEBRISOQUINE; OXYGENASE;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE DUPLICATION; GENOTYPE; HUMAN; HUMAN CELL; INHERITANCE; METABOLISM; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0007293059     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(96)00779-X     Document Type: Article

References (25)

1. [1] Cholerton, S., Daly, A.K. and Idle, J.R. (1992) Trends Pharmacol. Sci. 13, 434-439.
2. [2] Evans, D.A.P., Maghoub, A., Sloan, T.P., Idle, J.R. and Smith, R.L. (1980) J. Med. Genet. 17, 102-105.
3. [3] Brøsen, K. and Gram, L.F. (1989) Eur. J. Clin. Pharmaool. 36, 537-547.
4. [4] Kagimoto, M., Heim, M., Kagimoto, K., Zeugin, T. and Meyer, U.A. (1990) J. Biol. Chem. 265, 17209-17214.
5. [5] Daly, A.K., Armstrong, M., Monkman, S.C., Idle, M.E. and Idle, J.R. (1991) Pharmacogenetics 1, 33-41.
6. [6] Gaedigk, A., Blum, M., Gaedigk, R., Eichelbaum, M. and Meyer, U.A. (1991) Am. J. Hum. Genet. 48, 943-950.
7. [7] Evert, B., Griese, E.-U. and Eichelbaum, M. (1994) Naunyn-Schmiedelberg's Arch. Pharmacol. 350, 434-439.
8. [8] Evert, B., Griese, E.-U. and Eichelbaum, M. (1994) Pharmacogenetics 4, 271-274.
9. [9] Saxena, R., Shaw, G.L., Relling, M.V., Frame, J.N., Moir, D.T., Evans, W.E., Caporaso, N. and Weiffenbach, B. (1994) Hum. Mol. Genet. 3, 923-926.
10. [10] Daly, A.K., Leathart, J.B.S., London, S.J. and Idle, J.R. (1995) Hum. Genet. 95, 337-341.
11. [11] Steen, V.M., Andreassen, O.A., Daly, A.K., Tefre, T., Børresen, A.-L., Idle, J.R. and Gulbrandsen, A.-K. (1995) Pharmacogenetics 5, 215-223.
12. [12] Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M-.L., Sjøqvist, F. and Ingelman-Sundberg, M. (1993) Proc. Natl. Acad. Sci. USA 90, 11825-11829.
13. [13] Agundez, J.A.G., Ledesma, M.C., Ladero, J.M. and Benitez, J. (1995) Clin. Pharmacol. Ther. 57, 265-269.
14. [14] Dahl, M.-L., Johansson, I., Bertilsson, L., Ingelman-Sundberg, M. and Sjøqvist, F. (1995) J. Pharmacol. Exp. Ther. 274, 516-520.
15. [15] Bertilsson, L., Åberg-Wistedt, A., Gustafsson, L.L. and Nordin, C. (1985) Ther. Drug. Monit. 7, 478-180.
16. [16] Bertilsson, L., Dahl, M.-L., Sjøqvist, F., Åsberg-Wistedt, A., Humble, M., Johansson, I., Lundqvist, E. and Ingelman-Sundberg, M. (1993) Lancet 341, 63.
17. [17] Skoda, R.C., Gonzalez, F.J., Demierre, A. and Meyer, U.A. (1988) Proc. Natl. Acad. Sci. USA 85, 5240-5243.
18. [18] Kimura, S., Umeno, M,. Skoda, R.C., Meyer, U.A. and Gonzales, F.J. (1989) Am. J. Hum. Genet. 45, 889-904.
19. [19] Heim, M. and Meyer, U.A. (1992) Genomics 14, 49-58.
20. [20] Steen, V.M., Molven, A., Aarskog, N.K. and Gulbrandsen A-.K. (1995) Hum. Mol. Genet. 4, 2251-2257.
21. [21] Daly, A.K., Brockmöller, J., Broly, F., Eichelbaum, M., Evans, W.E., Gonzales, F.J., Huang, J.-D., Idle, J.R., Ingelman-Sundberg, M., Ishizaki, T., Jacqz-Aigrain, E., Meyer, U.A., Nebert, D.W., Steen, V.M., Wolf, C.R. and Zanger, U.M. (1996) Pharmacogenetics, in press.
22. [22] London, S.J., Daly, A.K., Cooper, J., Navidi, W.C., Carpenter, C.L. and Idle, J.R. (1995) J. Natl. Cancer Inst. 87, 1246-1253.
23. [23] Tefre, T., Daly, A.K., Armstrong, M., Leathart, J.B.S., Idle, J.R., Brøgger, A. and Børresen, A.-L. (1994) Pharmacogenetics 4, 47-57.
24. [24] Armstrong, M., Idle, J.R. and Daly, A.K. (1993) Hum. Genet. 91, 616-617.
25. [25] Masimirembwa, C.M., Johansson, I., Hasler, J.A. and Ingelman-Sundberg, M. (1993) Pharmocogenetics 3, 275-280.